GRN Klinik Weinheim
- Address
- Röntgenstr.1, 69469 Weinheim, Germany
GRN Klinik Weinheim - Breast Cancer Research Center
GRN Klinik Weinheim is a specialized clinical research center focusing on advancing treatment strategies for various subtypes of breast cancer. The center demonstrates particular expertise in personalized and targeted therapeutic approaches, conducting pivotal phase III trials that evaluate novel treatment combinations and marker-adjusted therapy regimens.
- Triple-negative early breast cancer with neoadjuvant immunotherapy and antibody-drug conjugate combinations
- Hormone receptor-positive, HER2-negative early breast cancer with CDK4/6 inhibitor therapy
- Advanced HER2-negative, hormone receptor-positive breast cancer investigating resistance patterns and survival outcomes
The center's research portfolio emphasizes dynamic marker-adjusted personalized therapy and comprehensive molecular profiling to optimize treatment selection. Their clinical trials investigate cutting-edge therapeutic agents including sacituzumab govitecan, pembrolizumab, abemaciclib, and ribociclib, with a focus on improving disease-free survival and overall survival outcomes. The center's commitment to precision oncology is evident through their participation in studies analyzing spatial, temporal, and molecular patterns of treatment efficacy and resistance mechanisms in breast cancer patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in GRN Klinik Weinheim
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCER PATIENTS | Institut fuer Frauengesundheit GmbH | Phase III | Recruiting | Oct 2022 | — |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abemaciclib | 1 | Unknown | 2020-07-23 | 2020-07-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.